Antje Willuweit studied biology at the University of Technology, Darmstadt (Germany) and received her PhD from the Max-Planck-Institute in Bad Nauheim (Germany). She gained nine years of industrial experience in the following biotech companies: Artemis Pharmaceuticals GmbH, Evotec Neurosciences AG, and Evotec AG. In 2011 she joined the Jülich Research Center (Forschungszentrum Jülich) at the Institute of Neuroscience and Medicine (INM-4), where she established her own research group. She joined Priavoid as a co-founder in 2017. In total, she has more than 20 years of experience with pre-clinical models in pre-clinical research, including at least 17 years in the field of pre-clinical drug testing against Alzheimer´s disease and other neurodegenerative diseases.